Haemonetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.About HAE
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital.
HAE Key Statistics
Stock Snapshot
As of today, Haemonetics(HAE) shares are valued at $120.37. The company's market cap stands at 5.48B, with a P/E ratio of 54.97.
On 2026-11-20, Haemonetics(HAE) stock traded between a low of $119.37 and a high of $123.96. Shares are currently priced at $120.37, which is +0.8% above the low and -2.9% below the high.
Haemonetics(HAE) shares are trading with a volume of 426.26K, against a daily average of 619.76K.
In the last year, Haemonetics(HAE) shares hit a 52-week high of $132.00 and a 52-week low of $51.00.
In the last year, Haemonetics(HAE) shares hit a 52-week high of $132.00 and a 52-week low of $51.00.
HAE News
...
Citizens raised the firm’s price target on Haemonetics (HAE) to $144 from $115 and keeps an Outperform rating on the shares. Haemonetics delivered broad-based s...
Haemonetics reported second quarter fiscal 2027 sales of US$357.76 million and net income of US$46.31 million, raised full year 2027 revenue guidance to 8% to 1...
Analyst ratings
77%
of 13 ratingsMore HAE News
Haemonetics earnings and guidance reset the story Haemonetics (HAE) has investors’ attention after second quarter results showed higher sales and profit than a...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.